ARCT News and Press, Arcturus Therapeutics Ltd. From 09/08/20

SAN DIEGO, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportu...

Encouraging preclinical results demonstrate a strong antibody and cellular immune response and 100% protection against SARS-CoV-2 infection following a single vaccination Clinical study remains on track, initial data readout expected Q4 2020 SAN DIEGO, Sept. 04, 2020 (GLOBE NEWSW...

It's been a while since I went through the whole vaccine landscape (I've been putting it off!), but there's a lot to catch up on. I'm going to incorporate some slightly reworked material from my July post in the introduction to each vaccine class, for reference, but everything on the candida...

The following slide deck was published by Arcturus Therapeutics Holdings Inc. in conjunction with this Read more ...

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

Volatility watch: Options volatility is running very high on Whiting Petroleum (NYSE: WLL ) , Sunesis Pharmaceuticals (NASDAQ: SNSS ) and Lipocine (NASDAQ: LPCN ) heading into next week, while notable short interest jumps have been seen with Macerich (NYSE: MAC ) , Teladoc (NYSE: T...

In an interview , Arcturus Therapeutics Holdings (NASDAQ: ARCT ) CEO Joseph Payne said that the company is in discussions with about a dozen countries in Europe, Latin America and Southeast Asia to supply its COVID-19 vaccine, ARCT-021, currently being tested in a recently launched  ...

SAN DIEGO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportun...

Written by Robert Kovacs Introduction Back in May, I wrote an article in which I suggested that “ with or without a Covid-19 vaccine ”, Pfizer ( PFE ) was a buy. Since then the stock has dropped 15% and climbed back to the price it was a quarter ago. Pfizer is currently t...

Potential for highly differentiated COVID-19 vaccine profile with a single administration, at a low dose Clinical study data expected in Q4 2020 SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”...